At 7.1% CAGR, Europe Medical Tubing Market is Projected to be Worth US$ 6,075.17 Million by 2031, says Business Market Insights

According to Business Market Insights’ research, the Europe medical tubing market was valued at US$ 3,500.58 million in 2023 and is expected to reach US$ 6,075.17 million by 2031, registering a CAGR of 7.1% from 2023 to 2031. Tubes with advanced features such as biocompatibility and antimicrobial properties and expanding applications in biopharmaceutical processing are among the critical factors attributed to drive the Europe medical tubing market growth.

As healthcare evolves, the demand for advanced medical tubing solutions tailored to various applications is increasing. By creating tubing systems with enhanced features, such as antimicrobial properties or integrated drug delivery systems, the manufacturers can differentiate their innovations and meet the evolving consumer demands. Manufacturers are focusing on medical tubing made from advanced materials that enhance flexibility, durability, and biocompatibility. Biodegradable polymers and antimicrobial coatings help meet regulatory standards while improving patient outcomes. Companies such as Trelleborg Group, Medtronic, and Saint-Gobain offer antimicrobial tubing solutions. Fresenius Kabi offers antimicrobial medical tubing aimed at intravenous therapy and enteral feeding applications; this tubing is engineered to improve patient safety by reducing microbial contamination. With the burgeoning complexity of medical procedures, the need for specialized tubing solutions is also rising in specific applications. Manufacturers can customize tubing for medical devices such as catheters, endoscopes, and infusion systems by collaborating with healthcare professionals, ultimately enhancing the functionality and effectiveness of end products. In January 2022, Otsuka Pharmaceutical Factory, Inc. introduced "Actreen," a single-use catheter with a tube and connector. It can be used by patients who have lost the urge to urinate or who opt for self-catheterization due to the difficulty faced during urinating. Thus, the creation of innovative products generates significant opportunities for manufacturers in the medical tubing markets.

On the contrary, recalls due to product failure hamper the growth of Europe medical tubing market.

By type, the Europe medical tubing market is segmented into polyvinyl chloride (PVC), polyimide or nylons, PTFE or thermoplastic elastomers (TPES), thermoplastic polyurethanes (TPUS), polyvinylidene fluoride (PVDF), polypropylene and polyethylene, silicone, and others. The polyvinyl chloride (PVC) segment held 29.0% share of Europe medical tubing market share in 2023, amassing US$ 1,016.72 million. It is projected to garner US$ 1,737.49 million by 2031 to register 6.9% CAGR during 2023–2031.

In terms of structure, the Europe medical tubing market is segmented into single-lumen, multi-lumen, multi-layer extruded tubing, tapered or bump tubing, braided tubing, balloon tubing, corrugated tubing, heat shrink tubing, and others. The multi-layer extruded tubing segment held 19.3% share of Europe medical tubing market share in 2023, amassing US$ 673.93 million. It is projected to garner US$ 1,149.35 million by 2031 to register 6.9% CAGR during 2023–2031.

Based on application, the Europe medical tubing market is segmented into bulk disposable tubing, catheters and cannula, drug delivery systems, and others. The bulk disposable tubing segment held 35.6% share of Europe medical tubing market share in 2023, amassing US$ 1,245.49 million. It is projected to garner US$ 2,183.41 million by 2031 to register 7.3% CAGR during 2023–2031.

By end users, the Europe medical tubing market is segmented into hospital and clinics, ambulatory care centers, medical labs, and others. The hospital and clinics segment held 60.2% share of Europe medical tubing market share in 2023, amassing US$ 2,105.67 million. It is projected to garner US$ 3,623.26 million by 2031 to register 7.0% CAGR during 2023–2031.

Based on country, the Europe medical tubing market is categorized into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Our regional analysis states that the Rest of Europe captured 30.0% share of Europe medical tubing market in 2023. It was assessed at US$ 1,051.81 million in 2023 and is likely to hit US$ 1,807.57 million by 2031, registering a CAGR of 7.0% during 2023–2031.

Key players operating in the medical tubing market are Air Liquide Medical Systems; Armstrong Medical Ltd; Besmed Health Business Corp; BMC Medical Co Ltd; DeVilbiss Healthcare LLC; Dimar S.P.A.; Dragerwerk AG & Co KGaA; Fisher & Paykel Healthcare Corp Ltd; Hamilton Medical AG; Hangzhou Formed Medical Devices Co., Ltd; Intersurgical Ltd; Koninklijke Philips NV; Medline Industries LP; ResMed Inc; Sleepnet Corporation; SunMed Group Holdings LLC ( AirLife); and SURU INTERNATIONAL PVT. LTD., among others.

• In Oct-2024: RAUMEDIC extended its portfolio for biopharmaceutical fluid processing products and launched a new brand for biocompatible tubing. Further, the company expanding its global headquarters with a cutting-edge ISO-7 clean room manufacturing facility. Leveraging more than 70 years of polymer processing expertise, the company is offering its state-of-the-art product range directly to the broader market.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com